Immune checkpoint biology in health & disease: Immune checkpoint biology and autoimmunity in cancer patients
International Review of Cell and Molecular Biology · 2024
DOI: 10.1016/bs.ircmb.2023.04.003 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Review of Cell and Molecular Biology, 2024. Verfasst von Pierre Van Mol und 3 weiteren Autor:innen. Beteiligte Einrichtung: VIB - CCB Laboratory of Translational Genetics, KU Leuven, Leuven, Belgium; Pneumology - Respiratory Oncology, University Hospitals Leuven, Leuven, B…. Hauptthemen laut MEDLINE: Antineoplastic Agents, Immunological, Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 91 Literaturangaben. Gefördert von: Stichting Tegen Kanker, Horizon 2020 Framework Programme, Eric Fund.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Immune checkpoints (ICs) play a central role in maintaining immune homoeostasis. The discovery that tumours use this physiological mechanism to avoid elimination by the immune system, opened up avenues for therapeutic targeting of ICs as a novel way of treating cancer. However, this therapy a new array of autoimmune side effects, termed immune-related adverse events (irAEs). In this narrative review, we first recapitulate the physiological function of ICs that are approved targets for cancer immunotherapy (CTLA-4, PD-(L)1 and LAG-3), as the groundwork to critically discuss current knowledge on irAEs. Specifically, we summarize clinical aspects and examine a molecular classification and predisposing factors of irAEs. Finally, we discuss irAE treatment, particularly emphasizing how molecular knowledge is changing the current treatment paradigm.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- VIB - CCB Laboratory of Translational Genetics, KU Leuven, Leuven, Belgium; Pneumology - Respiratory Oncology, University Hospitals Leuven, Leuven, Belgium.
- VIB - CCB Laboratory of Translational Genetics, KU Leuven, Leuven, Belgium.
- Pneumology - Respiratory Oncology, University Hospitals Leuven, Leuven, Belgium. Electronic address: els.wauters@uzleuven.be.
Förderung
- Stichting Tegen Kanker
- Horizon 2020 Framework Programme
- Eric Fund
- European Commission
- Fonds Wetenschappelijk Onderzoek
- KU Leuven
Zitieren
APA
Van Mol, P., Donders, E., Lambrechts, D., & Wauters, E. (2024). Immune checkpoint biology in health & disease: Immune checkpoint biology and autoimmunity in cancer patients. International Review of Cell and Molecular Biology. https://doi.org/10.1016/bs.ircmb.2023.04.003
Vancouver
Van Mol P, Donders E, Lambrechts D, Wauters E. Immune checkpoint biology in health & disease: Immune checkpoint biology and autoimmunity in cancer patients. International Review of Cell and Molecular Biology. 2024. doi:10.1016/bs.ircmb.2023.04.003
BibTeX
@article{VanMol2024,
author = {Van Mol, Pierre and Donders, Elena and Lambrechts, Diether and Wauters, Els},
title = {Immune checkpoint biology in health & disease: Immune checkpoint biology and autoimmunity in cancer patients},
journal = {International Review of Cell and Molecular Biology},
year = {2024},
doi = {10.1016/bs.ircmb.2023.04.003}
}
EUVIMED